Apiam Animal Health (AHX.AX) Stock Price

Apiam Animal Health Price

ASX·CLOSED
0.88
​
Market closed

Over the last 9 years Apiam Animal Health grew revenue by 16.1% annually, reaching 206.92 M AUD. Earnings per share have grown at 20.6% per year over the last 9 years. For Apiam Animal Health, the net margin of 0.4% is down versus 4.0% a few years ago. At today's price the dividend yield works out to roughly 3.27%. The payout ratio is around 635% of earnings. The dividend has grown at 3.0% per year over the past 8 years. The consensus 12-month price target for Apiam Animal Health is 0.89 AUD, about 1.4% above where the stock trades today. Of 7 analysts, 0 rate the stock a buy — an overall Sell consensus.

Apiam Animal Health stock price

Access this data via the Eulerpool API

Apiam Animal Health business model & stock analysis

Apiam Animal Health Ltd. engages in the provision of genetics, veterinary services, wholesale, and retail of related products. The company is headquartered in Bendigo, Victoria. The company went IPO on 2015-12-15. The firm is engaged in the provision of veterinary products and services for production and companion animals across three segments: dairy and mixed, feedlot, and pigs. Its service areas include veterinary services, research, education, records, product supply and diagnostics. Its species and ancillary services include dairy services, swine and poultry services, beef feedlot services, equine services, sheep services, genetic services, and others. The flagship ProDairy Program developed by the Company is purposely designed for dairy farmers. Under the Fur Life Vet banner, its clinics are dedicated to small animals and its mixed practice clinics provide services for domestic pets and their owners, including the Best Mates Program. The company operates a vertically integrated business with logistics, wholesale procurement arm, laboratory services and manufactures autogenous vaccines and private label products.

Frequently asked questions about Apiam Animal Health

Analysts currently set an average price target of 0.89 AUD for the Apiam Animal Health stock (median: 0.89 AUD), implying +1.4 % versus the latest price. The consensus is based on 7 analyst ratings.

7 analysts currently rate the Apiam Animal Health stock: 0 recommend buying, 3 holding and 4 selling. For 2026, analysts expect Apiam Animal Health to generate revenue of 214.80 M AUD and earnings per share of 0.05 AUD.

Converted at the current exchange rate, the Apiam Animal Health share trades at 0.55 EUR (0.88 AUD).

The Apiam Animal Health share (AHX.AX) is listed on 1 stock exchanges, including: ASX (AHX.AX).

The expected revenue of Apiam Animal Health is 214.80 M AUD. This figure is based on current financial data and reflects the company's business performance.

The expected profit of Apiam Animal Health is 8.64 M AUD. The net profit reflects the company's profitability after deducting all expenses.

The price-to-earnings ratio (P/E) of Apiam Animal Health is currently 18.91. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the Apiam Animal Health stock.

The price-to-sales ratio (P/S) of Apiam Animal Health is currently 0.76. The P/S ratio compares the market capitalization to the annual revenue and serves as a valuation metric for the Apiam Animal Health stock.

The Eulerpool Quality Score for Apiam Animal Health is 6/10.

The ISIN of Apiam Animal Health is AU000000AHX0. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.

The ticker of Apiam Animal Health is AHX.AX. The ticker symbol is used to trade Apiam Animal Health shares on the stock exchange.

Fair ValueTerminal
0.74 AUD
Over-/UndervaluationTerminal
Fairly valued
Sector
Industry
Health Care Providers & Services
Number of shares
Employees
Revenue growth Ø5 years
EBIT growth Ø5 years
Net Income growth Ø5 years
Website apiam.com.au
Country
Australia
Currency
AUD
Initial public offering
Dec 15, 2015
ISIN
AU000000AHX0
Cusip
Q0996X139
Market capitalization
164.41 M AUDMicro Cap
52-Week Range
PEG
—
P/E ratio
P/Ee 2026
19.02
P/Ee 2027
17.86
P/S
P/Se
0.76
EV/EBIT
21.26
P/B Ratio
1.36
ROE (Return on Equity)
ROA (Return on Assets)
ROCE (Return on Capital Employed)
ROIC (Return on Invested Capital)
0.37 %
Dividend
Dividend yield
3.27 %
Est. Dividend Yield
17.96 %
Payout Ratio
634.92 %
Dividend growth Ø5Y
41.07 %
Dividend payments per year
2
Dividend paid since
2 years
Dividend not reduced since
2 years
Dividend increased since
0 years
Dividend withholding tax
30.00 %
Last updated Oct 10, 2026, 3:27 PM

Apiam Animal Health Peer Group

Apiam Animal Health Ticker

ASX · AHX.AX

Apiam Animal Health FIGI

AHX:AU · BBG00BGQN638AHX:AT · BBG00BGQN647AHX:AH · BBG00BGQN683

All fundamentals and in-depth analysis of Apiam Animal Health

Our stock analysis for Apiam Animal Health stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Apiam Animal Health. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.